or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO C -0.47 3.83
    NVS B 0.53 2.73
    ASML D 0.36 2.71
    SONY F -4.04 2.33

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Animation Anti Diabetic Drugs Antibiotics Argon Biopharmaceutical Biotechnology Blood Test Consumer Electronics Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs Electric Vehicle Industry Electronic Equipment
    Industries: Biotechnology Consumer Electronics Drug Manufacturers - Major Semiconductor Equipment & Materials

    Recent News for Putnam ETF Trust Putnam PanAgora ESG International Equity ETF & its Holdings

    Date Stock Title
    May 8 SONY Sony Earnings: Expect Subpar Results, But Long Term Still Intact
    May 8 SONY Warner Bros. Discovery history: Beyond the Ticker
    May 8 NVO Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
    May 8 SONY Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    May 8 ASML ASML Holding N.V. (AMS:ASML) is favoured by institutional owners who hold 58% of the company
    May 8 SONY Nikkei Drops 0.6% Amid Caution Ahead of Toyota Earnings
    May 7 NVO 13 Best Stocks That Will Always Grow
    May 7 SONY Sony's Bold $26B Paramount Bid Raises Eyebrows: Can They Finance It?
    May 7 NVS Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 7 SONY Nintendo Teases Switch Successor After Weak Guidance
    May 7 SONY Sony Shares Fall as Paramount Deal Spurs Financing Concerns
    May 6 ASML Better AI Stock: Super Micro Computer vs. ASML
    May 6 NVO Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
    May 6 SONY Paramount deal talks: How investors are viewing risks
    May 6 SONY Paramount opens acquisition talks with Sony, Apollo: NYT
    May 6 NVO Investors Pile Into Amgen in Search of Next Obesity Drug Payout
    May 6 NVO Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
    May 6 NVO 'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
    May 6 SONY Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
    May 5 SONY 'The Fall Guy' leads weekend box office with $28.5M take
    The fund invests mainly in common stocks (growth or value stocks or both) of companies of any size outside the United States with a focus on companies that the fund"s subadviser, believes offer attractive benchmark-relative returns and exhibit positive environmental, social and governance ("ESG") metrics. The fund"s equity investments may include common stocks, preferred stocks, convertible securities, warrants, American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs").
    American Depositary Receipt Options Global Depository Receipt
    Back to the Main PPIE Page...